Evidence map›Paper›PMID 31974702›Full record

ArticleEJNMMI research2020

Low-dose

Edwin E G W Ter Voert, Hanna Svirydenka, Julian Müller, Anton S Becker, Miroslav Balaz, Vissarion Efthymiou, Claudia Irene Maushart, Gani Gashi, Christian Wolfrum, Matthias J Betz and 1 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Estimation of the Internal Dose Imparted byFrontiers in nuclear medicine · 2022
    Article
  4. Comparative [Adipocyte · 2020
    Article
  5. Comparison of [EJNMMI research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Edwin E G W Ter VoertDepartment of Nuclear Medicine, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland. Edwin.terVoert@usz.ch.ORCID http://orcid.org/0000-0001-8877-338X
Hanna SvirydenkaDepartment of Nuclear Medicine, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Julian MüllerDepartment of Nuclear Medicine, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
Anton S BeckerDepartment of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland.
Miroslav BalazDepartment of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland.
Vissarion EfthymiouDepartment of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland.
Claudia Irene MaushartDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Gani GashiDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Christian WolfrumDepartment of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH Zürich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland.
Matthias J BetzDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
Irene A BurgerDepartment of Nuclear Medicine, University Hospital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland.
ETH Zurich · CHUniversity of Basel · CHUniversity Hospital of Zurich · CHInnsbruck Medical University · ATUniversity of Zurich · CH

Funding

Swiss National Science Foundation grant no. PZ00P3_167823
6 · The paper itself

Abstract

backgroundPositron emission tomography (PET) is increasingly applied for in vivo brown adipose tissue (BAT) research in healthy volunteers. To limit the radiation exposure, the injected

methodsTwenty datasets from 13 volunteers were retrospectively included from a prospective clinical study. PET emission datasets were modified to simulate step-wise reductions of the original 75 MBq injected dose. The resulting PET images were visually and quantitatively assessed and compared to a 4-min reference scan. For the visual assessment, the image quality and artifacts were scored using a 5-point and a 3-point Likert scale. For the quantitative analysis, image noise and artifacts, BAT metabolic activity, BAT metabolic volume (BMV), and total BAT glycolysis (TBG) were investigated.

resultsThe visual assessment showed still good image quality for the 35%, 30%, and 25% activity reconstructions with no artifacts. Quantitatively, the background noise was similar to the reference for the 35% and 30% activity reconstructions and the artifacts started to increase significantly in the 25% and lower activity reconstructions. There was no significant difference in supraclavicular BAT metabolic activity, BMV, and TBG between the reference and the 35% to 20% activity reconstructions.

conclusionsThis study indicates that when the PET acquisition time is matched to the 10-min MRI protocol, the injected

Indexed as

18F-FDGBrown adipose tissueClinicalDose optimizationPET/MRSupraclavicular region

Identifiers

PMID31974702
PMCPMC6977803
OpenAlexW3005280596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.